163 related articles for article (PubMed ID: 37693224)
1. Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging.
Rentz DM; Klinger HM; Samaroo A; Fitzpatrick C; Schneider OR; Amagai S; Peipert JD
Alzheimers Dement (Amst); 2023; 15(3):e12473. PubMed ID: 37693224
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.
Alegret M; Valero S; Ortega G; Espinosa A; Sanabria A; Hernández I; Rodríguez O; Rosende-Roca M; Mauleón A; Vargas L; Martín E; Ruíz A; Tárraga L; Amariglio RE; Rentz DM; Boada M
Arch Clin Neuropsychol; 2015 Nov; 30(7):712-20. PubMed ID: 26289054
[TBL] [Abstract][Full Text] [Related]
3. Validation and Normative Data of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME).
Alviarez-Schulze V; Cattaneo G; Pachón-García C; Solana-Sánchez J; Tormos-Muñoz JM; Alegret M; Pascual-Leone A; Bartrés-Faz D;
J Int Neuropsychol Soc; 2022 Jan; 28(1):74-84. PubMed ID: 33749568
[TBL] [Abstract][Full Text] [Related]
4. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease.
Vila-Castelar C; Muñoz N; Papp KV; Amariglio RE; Baena A; Guzmán-Vélez E; Bocanegra Y; Sanchez JS; Reiman EM; Johnson KA; Sperling RA; Lopera F; Rentz DM; Quiroz YT
Alzheimers Res Ther; 2020 Sep; 12(1):104. PubMed ID: 32912283
[TBL] [Abstract][Full Text] [Related]
5. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.
Papp KV; Amariglio RE; Dekhtyar M; Roy K; Wigman S; Bamfo R; Sherman J; Sperling RA; Rentz DM
Clin Neuropsychol; 2014; 28(5):771-85. PubMed ID: 24815535
[TBL] [Abstract][Full Text] [Related]
6. Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
Karpouzian-Rogers T; Ho E; Novack M; Chinkers M; Bedjeti K; Nowinski C; Giordani B; Gershon R; Weintraub S
Alzheimers Dement; 2023 May; 19(5):1974-1982. PubMed ID: 36396612
[TBL] [Abstract][Full Text] [Related]
7. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.
Sanabria A; Alegret M; Rodriguez-Gomez O; Valero S; Sotolongo-Grau O; Monté-Rubio G; Abdelnour C; Espinosa A; Ortega G; Perez-Cordon A; Gailhajanet A; Hernandez I; Rosende-Roca M; Vargas L; Mauleon A; Sanchez D; Martin E; Rentz DM; Lomeña F; Ruiz A; Tarraga L; Boada M;
Sci Rep; 2018 Feb; 8(1):3828. PubMed ID: 29491481
[TBL] [Abstract][Full Text] [Related]
8. Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.
Alegret M; Rodríguez O; Espinosa A; Ortega G; Sanabria A; Valero S; Hernández I; Rosende-Roca M; Vargas L; Abdelnour C; Mauleón A; Gailhajanet A; Martín E; Tárraga L; Rentz DM; Amariglio RE; Ruíz A; Boada M
J Alzheimers Dis; 2015; 48(4):1109-17. PubMed ID: 26444795
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Latin American Spanish version of the face-name associative memory exam in a Colombian Sample.
Vila-Castelar C; Papp KV; Amariglio RE; Torres VL; Baena A; Gomez D; Rendon J; Samaroo A; Lopera F; Rentz DM; Quiroz YT
Clin Neuropsychol; 2020 Dec; 34(sup1):1-12. PubMed ID: 31851865
[TBL] [Abstract][Full Text] [Related]
10. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.
Alegret M; Muñoz N; Roberto N; Rentz DM; Valero S; Gil S; Marquié M; Hernández I; Riveros C; Sanabria A; Perez-Cordon A; Espinosa A; Ortega G; Mauleón A; Abdelnour C; Rosende-Roca M; Papp KV; Orellana A; Benaque A; Tarraga L; Ruiz A; Boada M
Alzheimers Res Ther; 2020 Mar; 12(1):25. PubMed ID: 32178724
[TBL] [Abstract][Full Text] [Related]
11. Performance on the Latin American version of the Face-Name Associative Memory Exam (LAS-FNAME) distinguishes individuals with Mild Cognitive Impairment from age-matched controls in a sample from Argentina.
Keller G; Corvalan N; Carello MA; Arruabarrena MM; Martínez-Canyazo C; De Los Santos L; Spehrs J; Vila-Castelar C; Allegri RF; Quiroz YT; Crivelli L
Appl Neuropsychol Adult; 2024 Mar; ():1-9. PubMed ID: 38447166
[TBL] [Abstract][Full Text] [Related]
12. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods.
Weintraub S; Karpouzian-Rogers T; Peipert JD; Nowinski C; Slotkin J; Wortman K; Ho E; Rogalski E; Carlsson C; Giordani B; Goldstein F; Lucas J; Manly JJ; Rentz D; Salmon D; Snitz B; Dodge HH; Riley M; Eldes F; Ustsinovich V; Gershon R
Alzheimers Dement; 2022 Aug; 18(8):1449-1460. PubMed ID: 34786833
[TBL] [Abstract][Full Text] [Related]
13. Extended FNAME performance is preserved in subjective cognitive decline but highly affected in amnestic mild cognitive impairment.
Flores-Vázquez JF; Contreras-López JJ; Stegeman R; Castellanos-Maya O; Ćurčić-Blake B; Andrés P; Sosa-Ortiz AL; Aleman A; Enriquez-Geppert S
Neuropsychology; 2023 Sep; 37(6):650-660. PubMed ID: 36480377
[TBL] [Abstract][Full Text] [Related]
14. Face-name associative memory performance is related to amyloid burden in normal elderly.
Rentz DM; Amariglio RE; Becker JA; Frey M; Olson LE; Frishe K; Carmasin J; Maye JE; Johnson KA; Sperling RA
Neuropsychologia; 2011 Jul; 49(9):2776-83. PubMed ID: 21689670
[TBL] [Abstract][Full Text] [Related]
15. Correction to "Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging".
Alzheimers Dement (Amst); 2023; 15(4):e12488. PubMed ID: 37854771
[TBL] [Abstract][Full Text] [Related]
16. Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals.
Kormas C; Megalokonomou A; Zalonis I; Evdokimidis I; Kapaki E; Potagas C
Clin Neuropsychol; 2018; 32(sup1):152-163. PubMed ID: 29966491
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Face Name Associative Memory Exam in cognitively normal older individuals.
Amariglio RE; Frishe K; Olson LE; Wadsworth LP; Lorius N; Sperling RA; Rentz DM
J Clin Exp Neuropsychol; 2012; 34(6):580-7. PubMed ID: 22765048
[TBL] [Abstract][Full Text] [Related]
18. I know your face but can't remember your name: Age-related differences in the FNAME-12NL.
Enriquez-Geppert S; Flores-Vázquez JF; Lietz M; Garcia-Pimenta M; Andrés P
Arch Clin Neuropsychol; 2021 Jul; 36(5):844-849. PubMed ID: 33159522
[TBL] [Abstract][Full Text] [Related]
19. The Face-Name Associative Memory Test as a Tool for Early Diagnosis of Alzheimer's Disease.
Rubiño J; Andrés P
Front Psychol; 2018; 9():1464. PubMed ID: 30154753
[TBL] [Abstract][Full Text] [Related]
20. Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.
Fristed E; Skirrow C; Meszaros M; Lenain R; Meepegama U; Papp KV; Ropacki M; Weston J
Brain Commun; 2022; 4(5):fcac231. PubMed ID: 36381988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
